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ABSTRACT 
Purpose: It is unclear whether protein supplementation augments the gains in muscle 
strength and size observed following resistance training (RT), as limitations to 
previous studies include small cohorts, imprecise measures of muscle size and 
strength, and no control of prior exercise or habitual protein intake (HPI). We aimed 
to determine whether whey protein supplementation affected RT-induced changes in 
elbow flexor muscle strength and size. Methods: We pair-matched 33 previously 
untrained, healthy young men for their HPI and strength response to 3-wk RT without 
nutritional supplementation (followed by 6-wk no training), and then randomly 
assigned them to protein (PRO; n = 17) or placebo (PLA; n = 16) groups. Participants 
subsequently performed elbow flexor RT 3 d/wk for 12-wk and consumed PRO or 
PLA immediately before and after each training session. We assessed elbow flexor 
muscle strength [unilateral 1-RM and isometric maximum voluntary force (MVF)] 
and size [total volume and maximum anatomical cross-sectional area (ACSAmax) 
determined with MRI] before and after the 12-wk RT. Results: PRO and PLA 
demonstrated similar increases in muscle volume (PRO, 17.0 ± 7.1% vs. PLA, 14.9 ± 
4.6%; P = 0.32), ACSAmax (PRO, 16.2 ± 7.1% vs. PLA, 15.6 ± 4.4%; P = 0.80), 1-
RM (PRO, 41.8 ± 21.2% vs. PLA, 41.4 ± 19.9%; P = 0.97) and MVF (PRO, 12.0 ± 
9.9% vs. PLA, 14.5 ± 8.3%; P = 0.43). Conclusion: In the context of this study, 
protein supplementation did not augment elbow flexor muscle strength and size 
changes that occurred after 12-wk RT.  
 
Key words: Protein supplementation – strength training – muscle hypertrophy – 
muscle architecture – training response 
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INTRODUCTION 
Paragraph Number (PN) 1: Both resistance exercise (4) and protein ingestion (31) 
are known to stimulate muscle protein synthesis (MPS), which is necessary for the 
accretion of skeletal muscle mass. Moreover, combining protein or amino acid 
ingestion with an acute bout of resistance exercise has been shown to further augment 
MPS (32). Based on these acute studies, it is surprising that the evidence for protein 
supplementation (PRO) enhancing the gains in muscle size and strength following 
longer term RT programs in young men remains equivocal (17, 24).  
 
PN 2: It has been suggested that the muscle strength (9, 40) and size (1, 17) responses 
to RT in young men may be amplified by PRO, although these effects are often 
marginal (20). In contrast, other studies in young men have shown no effect of PRO 
on gains in muscle size (8, 24) or strength (1, 24). Greater increases in muscle fiber 
area (1, 17) and myofibrillar protein content (40) have been observed when RT was 
combined with PRO rather than carbohydrate. However, none of these studies 
included detailed measurements of whole muscle size.  
 
PN 3: The apparent discrepancy between the acute studies of a single training bout 
and the longer-term RT studies may be compounded by a range of methodological 
issues with the latter. Firstly, the individual response to RT is known to vary widely 
between individuals (13, 19), yet numerous studies have used small participant groups 
(16, 20, 40) that may not have been powered to detect an influence of PRO. The 
impact of inter-individual variability might also be reduced by greater experimental 
control of prior physical activity and habitual protein intake. Secondly, some studies 
have used crude measures of muscle hypertrophy, such as dual-energy X-ray 
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absorptiometry to assess whole body fat-free mass (17) or muscle thickness 
determined with ultrasonography (7, 35). Thirdly, in the context of nutritional 
supplementation, no study has attempted to minimize or quantify the neural changes 
that occur with RT, which together with muscle hypertrophy, are considered the major 
contributors to strength improvements (15). Thus, large and variable neural 
improvements could have confounded the potential influence of PRO on training-
induced changes in muscle size and strength in previous studies. Finally, the 
resistance exercise model that has been most commonly researched has involved 
lower limb training (1, 8, 34) despite the upper limb musculature showing greater 
adaptive responses to resistance training (10, 37). Therefore, an elbow flexor exercise 
model may offer a better chance of discriminating an influence of PRO on muscle 
hypertrophy and strength changes following RT.  
 
PN 4: Taking all the above factors into account, we aimed to compare the training-
induced changes in elbow flexor muscle size, architecture and strength between two 
groups of previously untrained young men supplemented with either protein or 
placebo. We hypothesized that 20 g (26) whey protein (31) ingested immediately 
before (33) and after (14) each training session would confer greater changes in 
muscle size and strength after 12 weeks of RT, compared to RT alone.  
 
METHODS 
Participants  
PN 5: Thirty-three healthy young men (mean ± SD: age, 23 ± 3 yrs; height, 1.76 ± 
0.06 m; body mass, 75.2 ± 10.7 kg) provided written informed consent prior to 
completing this 25-week study, which complied with the Declaration of Helsinki and 
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was approved by the Ethical Advisory Committee of Loughborough University. 
Volunteers were excluded from taking part in the study if they: were vegans; had 
unusually high (>2 g⋅kg-1⋅day-1) or low (<0.8 g⋅kg-1⋅day-1) protein intake (see below); 
reported use of potentially anabolic supplements in the previous 6 months or were 
taking any medication considered to influence muscle size or function; had a history 
of upper body exercise in the previous 12 months; were <18 or >30 yrs old.  
 
Study overview 
PN 6: The study was a single-centre, double-blind design. Participants completed 3-
wk elbow flexor RT without nutritional supplementation, 6-wk of no training, and 
then 12-wk elbow flexor RT with nutritional supplementation (Fig. 1A). The 3-wk RT 
period was conducted to standardize training status prior to the 12-wk RT, and to 
overcome neural adaptations that occur within the first few weeks of RT (27). The 6-
wk of no training provided a clear break between the training periods to improve 
participant retention, and has been shown to result in only a modest detraining effect 
(23). During the 6-wk no RT participants were pair-matched for their isometric 
strength response to the 3-wk RT and their normal protein intake (Table 1), and 
randomly assigned to PRO (n = 17) or PLA (n = 16) supplementation groups. The 
groups had similar age, elbow flexor muscle strength and size, anthropometric, 
physical activity and nutritional characteristics (Table 1). Participants then completed 
12-wk RT, during which they received PRO or PLA supplementation. Measurements 
of the dominant arm were performed before and 3-4 days after the 12-wk RT in the 
following order: muscle architecture (assessed with ultrasonography); dynamic and 
isometric strength (agonist and antagonist muscle activation was determined with 
sEMG); muscle size was assessed with magnetic resonance imaging (MRI) at least 
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24-h after strength testing to ensure that measurements were not influenced by 
exercise-induced fluid shifts. All testing took place between 09:00 and 18:00 and, for 
each participant, tests were performed at the same time of day before and after 
training. Participants were instructed not to participate in strenuous physical activity, 
consume alcohol or excessive amounts of caffeine in the 24-hr prior to measurement 
sessions, and to maintain their habitual diet and lifestyle throughout the study. 
 
Table 1 near here.  
 
Resistance training (RT) 
PN 7: During both RT periods participants performed 3 training sessions per week 
(Monday, Wednesday and Friday). Each session commenced with unilateral bicep 
curls using dumbbells and a modified preacher bench (Body Solid, Forest Park, IL) 
and sets were performed alternately with each arm. Subsequently, bilateral bicep curls 
were performed on a resistance training machine (Pro Club Line Bicep Curl; Body 
Solid, Forest Park, IL). The loading for both exercises was 8-10 RM and the load was 
increased when participants could lift 10 reps during the final set of an exercise. The 
3-wk RT involved 2 sets of each exercise, i.e. 2 sets for each unilateral arm exercise; 
2 sets bilateral, with 2 min rest between each set. This was the same for wk 1-2 of the 
12-wk RT, but increased to 3 sets (unilateral) and 2 sets (bilateral) during wk 3-4 and 
3 sets of both exercises for wk 5-12. Apart from the supplementation provided, 
participants were instructed to consume only water in the 2 hr before and 1.5 hr after 
each training session, and to facilitate this, training sessions took place either mid-
morning (10:00 to 11:00) or mid afternoon (14:30 to 16.30). Furthermore, every 
participant completed all 36 training sessions.  
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Supplementation 
PN 8: Participants were given their supplementation in a double-blind manner in the 
form of an opaque drinks bottle containing 250 ml fluid, which was fully consumed 
immediately before, and another immediately after, each RT session. The PRO 
supplement comprised water mixed with 30 g powder that contained 20 g whey 
protein (~50% essential amino acids), 6.7 g lactose, together with flavoring and 
sweeteners. Thus, the total protein supplementation on training days was 40 g·d-1, and 
when averaged across training and non-training days, the PRO supplement increased 
protein intake by 17.1 g·d-1, carbohydrate intake by 5.7 g·d-1 and energy intake by 
91.2 kcal·d-1. Each PLA supplement contained 6.8 g of lactose and, when averaged 
over training and non-training days, increased carbohydrate intake by 5.8 g·d-1 and 
energy intake by 23.2 kcal·d-1. 
 
Neuromuscular measurements and protocol 
Muscle architecture  
PN 9: Fascicle pennation angle (θp, the angle between the fascicular paths and their 
insertion into the deep aponeurosis) of the biceps brachii short head (BBS) and 
brachialis (BRACH) muscles was examined using B-mode ultrasonography (SSA-
37OA Power Vision 6000, Toshiba, Otawara-Shi, Japan) with an 8 MHz linear-array 
transducer. Participants lay supine with the dominant elbow extended and the 
shoulder abducted by 90°. Strips of ultrasound-absorbent tape (2 mm wide; 3M, 
Neuss, Germany) were placed perpendicular to the long axis of the BBS at 50 mm 
intervals from the cubital crease to the shoulder, which formed markers on the 
sonographs and enabled θp to be analyzed at the same location pre and post RT. A 
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midline between the medial and lateral boundaries of the BBS was marked along the 
length of the muscle. The probe (coated with gel) was applied to the cubital crease 
with minimal pressure and carefully glided along this line to the proximal end of BBS 
(in line with the direction of the muscle fascicles). Sonographs were analyzed offline 
using a public domain software package (NIH ImageJ, Bethesda, MD). Fascicle θp 
was determined in 3 BBS fascicles within 50 mm of its distal end and in 3 BRACH 
fascicles within 50 mm of its proximal end. The mean of the three measurements 
determined θp for each muscle and the test-retest coefficient of variation (CV) for this 
assessment was 2.9%.  
 
Unilateral single repetition maximum (1-RM) 
PN 10: Unilateral bicep curl 1-RM lifting strength was assessed with a series of 
incremental dumbbell lifts using the modified preacher bench that was used in 
training. The bench was customized with a horizontal rack at full elbow extension, 
which provided a consistent starting position for the 1-RM lift. The height of the 
padded arm support was adjusted to arm length, ensuring the elbow was fully 
extended when the hand gripped the dumbbell on the rack. The warm-up comprised 
10 reps at 40% of the previous 1-RM and, after 1 min rest, 3 reps were performed at 
80% of the previous 1-RM. Thereafter, a series of single lifts (concluding at full 
flexion, at which point the investigator removed the dumbbell from the participant) 
were performed interspersed with 1 min rest intervals, firstly at the previous 1-RM, 
and then at increments of +0.5 kg if the preceding lift was successful. The 1-RM was 
generally determined within 3-5 attempts, although more attempts were completed if 
necessary. The test-retest CV for this assessment was 3.5%.  
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Isometric maximum voluntary force (MVF) 
PN 11: Elbow flexor isometric strength was measured using a custom-built strength-
testing chair (Fig. 1B) and the elbow joint angle fixed at 120° (180º = full elbow 
extension). The participant sat upright (hip joint angle of 90°) and was strapped at the 
hip and chest to the seat and back of the chair to prevent movement of the body. The 
shoulder joint was flexed to 90° with the upper arm placed on a horizontal board, and 
externally rotated with the elbow position maintained by blocks anterior and lateral to 
the joint. The forearm was supinated, and the wrist strapped to an S-Beam tension-
compression load cell (Applied Measurements Ltd, Aldermaston, UK), which was 
positioned perpendicular to the direction of forearm movement during isometric 
elbow flexion/extension. The force signal was interfaced with an analogue to digital 
converter (CED micro 1401, Cambridge, UK), sampled at 2000 Hz with a PC using 
Spike 2 software (CED, Cambridge, UK) and low-pass filtered (500 Hz edge 
frequency) with a second order Butterworth digital filter. Following a warm up of four 
submaximal voluntary contractions, participants completed four elbow flexion 
isometric maximum voluntary contractions (MVCs) separated by ≥30 s, in which they 
were instructed to flex the elbow as hard as possible for 3 s. Biofeedback and verbal 
encouragement were provided during and in between each MVC. Participants then 
completed four isometric elbow extension MVCs with an identical protocol to 
determine the maximum surface EMG (sEMGmax) amplitude of the TB (see details 
below). MVF for elbow flexion and extension was the greatest instantaneous 
voluntary force achieved during that action and the test-retest CV for this assessment 
was 3.4%. 
 
Fig. 1 near here. 
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Surface electromyography (sEMG) 
PN 12: Surface EMG (Delsys Bagnoli-4, Boston, MA) was recorded from three 
agonist muscles (BBS, BBL and BR), and one antagonist muscle [lateral head of m. 
triceps brachii (TB)]. Following preparation of the skin (shaving, lightly abrading and 
cleansing with 70% ethanol), double-differential surface electrodes (1 cm inter-
electrode distance, Model DE-3.1; Delsys, Boston, MA) were attached over the belly 
of each muscle, parallel to the presumed orientation of the muscle fibers using 
adhesive interfaces, and a reference electrode placed on the clavicle. BBS and BBL 
electrodes were placed mid-belly at 25% of the distance from the medial epicondyle 
of the humerus to the coracoid process, i.e. distal to the motor point region of each 
head (22). The BR electrode was placed over the proximal third of the muscle belly, 
identified during a submaximal isometric “hammer curl”. Similarly, the TB electrode 
was placed over the distal third of the lateral head of the TB muscle, identified during 
a submaximal isometric elbow extension. Electrode locations were recorded for 
subsequent tests by measuring the distance from the centre of the electrode to the 
cubital crease (BBS, BBL and BR) or olecranon process (TB) with the elbow fully 
extended. Surface EMG signals were amplified (x100, differential amplifier 20-450 
Hz) and sampled at 2000 Hz with the same analogue to digital converter and PC as 
the force signal, prior to being band-pass filtered (6-500 Hz) using a 4th order zero-
lag Butterworth filter. The root mean square (RMS) of the sEMG signal of a 500 ms 
epoch around MVF (± 250 ms) was used to assess activation of agonist and antagonist 
muscles. To minimize the variability in absolute sEMG (6), sEMG recorded at elbow 
flexion MVF was normalized to the evoked supramaximal M-wave (compound 
muscle action potential), or Mmax, of the BBS and BBL (see below) and elbow 
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extension TB sEMGmax. Normalization of sEMG from the BR was not possible as it is 
not innervated purely by the musculocutaneous nerve, and thus a reliable Mmax cannot 
be evoked.  
 
Neural stimulation and evoked Mmax 
PN 13: A self-adhesive anode (5 x 5 cm; Verity Medical, Andover, UK) was attached 
to the skin over the TB muscle. The cathode (1 cm diameter, Electro Medical 
Supplies, Wantage, UK) was held to the skin over the musculocutaneous nerve, in 
between the BBS and BBL, at 50% of the distance between the medial epicondyle of 
the humerus and the coracoid process [the motor point of the BB muscle (22)]. The 
precise location of the cathode was determined as the position that, upon electrical 
stimulation (DS7AH, Digitimer Ltd., Welwyn Garden City, UK) with single square 
wave pulses (0.2 ms duration), evoked the greatest M-wave response from BBS and 
BBL for a particular submaximal electrical current (typically 3-5 stimuli at 30-50 
mA). M-waves were then evoked at 10-20 mA incremental current intensities until a 
plateau was achieved (typically between 80-140 mA). Thereafter, the electrical 
current was increased by 20% and three supramaximal M-waves were evoked. Mmax 
was defined as the mean peak-to-peak sEMG response to these 3 stimuli.  
 
Muscle size 
PN 14: A Magnetom Symphony 1.5-T MRI scanner (Siemens AG, Erlangen, 
Germany) was used to perform three overlapping scans (each comprising ~25 
contiguous axial ‘slices’ perpendicular to the humerus/radius) from the acromion 
process to below the distal end of the radius of the dominant arm, which was secured 
in supination to minimize movement while the participant lay supine. The following 
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parameters were used for each T1-weighted scan: time of repetition 420 ms; time to 
echo 1.2 sec; matrix 284 x 448 pixels; field of view 181 x 200 mm; slice thickness 10 
mm; interslice gap 0 mm. The scans were subsequently imported to a dicom image 
viewer (Osirix Foundation, Geneva, Switzerland) and using the lipid capsules that 
were placed on the skin mid-way along the humerus and radius, and anatomical 
markers (e.g. bone, blood vessel size, etc.), the relevant slice from the first scan was 
matched with the identical slice in the second scan, and so on. The ACSA of each 
muscle of interest (BB, BRACH and BR) was then manually outlined (excluding 
visible fat and connective tissue) and plotted against bone length (proximal end of the 
humerus to the distal end of the radius). A spline curve was fitted to the ACSA data 
points of each muscle and volume was calculated as the area under the curve (12); the 
sum of the three volumes provided total elbow flexor muscle volume. The largest 
ACSA (ACSAmax) was recorded for BB, BRACH and BR, and the sum of the three 
ACSAmax provided ∑ACSAmax. The test-retest CV for the assessment of total volume 
and ∑ACSAmax was 0.8% and 0.9%, respectively.  
 
Nutrient intake, anthropometry and physical activity  
PN 15: Participants used ‘Arc’ electronic weighing scales (Salter, Tonbridge, UK) to 
weigh and record their nutrient intake for 3 days (Thursday-Saturday) during both the 
3-wk and 12-wk RT periods (Fig. 1A). Records were scrutinized by a sports 
nutritionist and analyzed with Compeat v5.8 (Pro) software (Nutrition Systems, 
Grantham, UK). Participants who had an unusually high (>2 g·kg-1·d-1) or low (<0.8 
g·kg-1·d-1) protein intake during the 3-wk RT were excluded from the supplemented 
12-wk RT. Body mass and height were measured in conjunction with skin-fold 
thickness, which was assessed in duplicate at four sites (biceps, triceps, subscapular 
 13 
and iliac crest) using Harpenden skin-fold calipers (Baty International, Burgess Hill, 
UK), as changes in subcutaneous fat are likely to influence the sEMG signal and, 
therefore, the assessment of muscle activation. Further, % body fat was calculated 
from the sum of these four skin-folds (11, 30) and used to calculate fat-free mass. The 
test-retest CV for the assessment of % body fat was 0.8%. Habitual physical activity 
level (PAL) was assessed from a standard questionnaire (2) that was completed at the 
start and end of the whole study protocol (Fig. 1A). 
 
Statistical analysis 
PN 16: Analyses of raw data recordings were completed by the same investigator, 
who remained blinded to supplement group. Group data are expressed as mean ± 
standard deviation (SD). Between group comparisons for pre- and post-RT absolute 
values were compared with 2-way repeated measures ANOVA (group: PLA vs. PRO; 
time: pre vs. post). Comparisons between groups pre-training or for % change over 
the 12-wk supplemented RT period were performed with independent t-tests. 
Bivariate relationships were assessed with Pearson’s product moment correlations and 
statistical significance was defined as P < 0.05.  
 
RESULTS  
Muscle size and architecture 
PN 17: After 12 wks supplemented RT, total elbow flexor muscle volume increased 
from 413.4 ± 73.1 to 474.1 ± 80.1 cm3 (+17.0 ± 7.1%) for PRO and from 388.3 ± 61.9 
to 454.8 ± 81.5 cm3 (+14.9 ± 4.6%) for PLA, with no significance difference between 
the two groups (ANOVA, time P < 0.001, group x time P = 0.52; Table 2). The 
training-induced change in volume of the individual elbow flexors also showed no 
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effect of supplementation group (ANOVA, group x time: BB, P = 0.86; BRACH, P = 
0.68; BR, P = 0.77; Fig. 2A; Table 2).  
 
PN 18: ∑ACSAmax also displayed a clear effect of the training from 26.9 ± 4.3 to 31.3 
± 5.1 cm2 (+16.2 ± 7.1%) for PRO and from 28.5 ± 3.9 to 32.9 ± 4.5 cm2 (+15.6 ± 
4.4%) for PLA, but no difference between the groups (ANOVA, time P < 0.001, 
group x time P = 0.87; Table 2). Similarly, the changes in ACSAmax for each of the 
individual elbow flexor muscles were not influenced by supplementation (ANOVA, 
group x time 0.53 < P < 0.95; Table 2).  
 
PN 19: Training increased muscle fascicle θp of the BBS and BRACH in both the 
PRO (BBS, 18.5 ± 9.5%; BRACH, 15.7 ± 9.9%) and PLA (BBS, 15.8 ± 6.9%; 
BRACH, 14.6 ± 8.2%) supplementation groups, but these changes did not differ 
between the groups (ANOVA, group x time 0.65 < P < 0.89; Table 2). 
 
Table 2 near here.  
 
Muscle strength 
PN 20: Isometric MVF of the elbow flexors increased after 12-wks RT, but to a 
similar extent for both groups [PLA, 271.2 ± 43.0 to 309.7 ± 48.8 N (+14.5 ± 8.3%); 
PRO, 253.8 ± 41.1 to 283.8 ± 50.1 N (+12.0 ± 9.9%); ANOVA, time P < 0.001, group 
x time P = 0.32; Fig. 2B]. Following the 12-wk RT period, 1-RM lifting strength 
increased, although there was no difference between groups [PLA, 13.3 ± 3.2 to 18.3 
± 3.7 kg (+41.4 ± 19.9 %); PRO, 12.3 ± 2.7 to 17.2 ± 3.7 kg (41.8 ± 21.2 %); 
ANOVA, time P < 0.001, group x time P = 0.90; Fig. 2B).  
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Fig. 2 near here.  
 
Neurological changes during isometric elbow flexion 
PN 21: Two of the agonist muscles showed a drop in absolute sEMG at isometric 
maximum voluntary force (MVF) after training (ANOVA, time: BBL, P = 0.045; 
BBS, P = 0.049; BR P = 0.17; Table 3), but there were similar changes in Mmax and 
hence normalized sEMG was unchanged after training (ANOVA, time, BBL P = 
0.173; BBS, P = 0.56; Table 3). There was no interaction between supplementation 
group and RT for agonist sEMG (ANOVA, group x time: absolute values, 0.11 < P < 
0.80; normalized values, 0.60 < P < 0.95; Table 3). The percentage change in sEMG 
at isometric MVF also showed no difference between groups for the individual 
agonist muscles (Table 3). When data were collapsed across the agonist muscles there 
were no differences between the % changes recorded for the supplementation groups 
(absolute values: PLA, -9.5 ± 17.5% vs. PRO, -2.5 ± 27.6%, t-test P = 0.41; 
normalized values: PLA, 6.1 ± 34.1% vs. PRO, 0.0 ± 34.9%, t-test P = 0.63). 
Antagonist sEMG at elbow flexion MVF was unchanged in both groups (ANOVA, 
group x time: absolute values, P = 0.09; normalized values, P = 0.65).  
 
Table 3 near here.  
 
Nutrient intake, anthropometry and physical activity  
PN 22: There were no differences between groups in their normal dietary intake of 
energy or macronutrients during the 3-wk (Table 1) or supplemented 12-wk RT 
(Table 4), and no changes over time, either in absolute terms or normalized to body 
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mass (ANOVA, time P ≥ 0.459; group x time P ≥ 0.312; Table 4). On training days 
during the 12-wk RT, protein intake was significantly higher in PRO compared to 
PLA, both in absolute terms (PLA, 101.2 ± 27.2 g·d-1 vs. PRO, 139.6 ± 22.8 g·d-1; t-
test, P < 0.0005) and when normalized to body mass (PLA, 1.35 ± 0.47 g·kg-1·d-1 vs. 
PRO, 1.88 ± 0.37 g·kg-1·d-1; t-test, P = 0.002; Table 4). However, when supplement 
intake was averaged across training and non-training days, total protein intake was 
similar for both groups (absolute values; t-test, P = 0.09; normalized to body mass; t-
test, P = 0.12; Table 4), and carbohydrate, fat and total energy intake remained similar 
(t-test, P ≥ 0.47; Table 4).  
 
PN 23: Subcutaneous fat increased after the 12-wk RT period (ANOVA, time P = 
0.03) but there was no group interaction (ANOVA, group x time P = 0.09). There was 
a significant effect of the supplemented RT period on body mass (ANOVA, time P = 
0.005) and % body fat (ANOVA, time P = 0.022) over the 12-wk supplemented RT 
period. However, the changes in body mass (ANOVA, group x time P = 0.17; PLA, 
75.6 ± 11.4 to 77.1 ± 11.5 kg; PRO, 74.9 ± 10.3 to 75.5 ± 10.0 kg) and % body fat 
(ANOVA, group x time, P = 0.09; PLA, 21.5 ± 6.1 to 23.1 ± 6.3 %; PRO, 22.5 ± 5.1 
to 22.7 ± 4.9 %) were similar for the two groups. There were no changes in FFM 
during the supplemented RT (ANOVA, time P = 0.58, group x time P = 0.55; PLA, 
60.2 ± 10.2 to 60.2 ± 9.6 kg; PRO, 57.9 ± 7.5 to 58.2 ± 7.1 kg). 
 
PN 24: Prior to performing the 3-wk RT, the whole cohort had a PAL of 2.6 ± 0.4 
indicating that they were ‘recreationally active’, and it remained stable over the 
course of the study (post 12-wk RT, 2.6 ± 0.4). There was no difference in PAL 
between PLA and PRO (ANOVA, time P = 0.36, group x time P = 0.48), and the 
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mean PAL (pre and post) was unrelated to any of the training responses following the 
12-wk RT (R2 ≤ 0.06; P ≥ 0.17).  
 
Table 4 near here.  
 
DISCUSSION  
PN 25: The aim of this study was to determine the effect of protein supplementation 
(PRO) on changes in elbow flexor muscle size, architecture and strength following 12 
weeks of RT. By using sensitive, state of the art techniques, we found that PRO did 
not influence any of these training-induced adaptations.  
 
PN 26: There are a number of factors in our study that we thought would accentuate 
an effect of PRO on the training-induced changes in muscle size and strength: 1) it 
featured larger cohorts than have been used in most previous studies of this kind; 2) 
an initial pre-intervention RT period was included to overcome neural changes, 
standardize pre-intervention training status and familiarize participants with all 
training and measurement procedures; 3) participants included only young, healthy 
male participants that might be more responsive to RT (37) and PRO (36) than older 
individuals; 4) we employed an upper-limb RT program to maximize the muscle 
hypertrophic response. The measurements incorporated 1.5T MRI for documenting 
changes in muscle size, ultrasonographic assessments of muscle architecture, as well 
as careful functional measurements. In addition, possible confounding factors were 
considered prospectively by pair matching participants according to their normal 
nutrient intake and isometric strength response to the initial 3-wk of RT prior to their 
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random allocation to supplementation groups, and retrospectively by assessing normal 
dietary behavior and neural drive.  
 
PN 27: The ~16% changes in elbow flexor muscle volume and maximum ACSA 
observed in this study were similar to the 14-23% changes reported in previous upper 
limb RT studies (10, 19, 37). In spite of these substantial changes, there was no 
difference in muscle hypertrophy between PRO and PLA groups. Accepting the 
methodological differences between studies, this finding is broadly similar to previous 
investigations in young men (8, 20), post-menopausal women (18) and older people 
(34), which used MRI (8, 18, 20) or computer tomography (34) to quantify changes in 
lower-limb muscle ACSA following RT supplemented with PRO or PLA. The lower-
limb nature of these previous strength training studies resulted in markedly smaller 
changes in muscle size (5-10%) compared to those reported in our study, and thus 
may have restricted their capacity to determine any hypertrophic benefit of PRO. 
However, despite using a more responsive muscle group, our results suggest that PRO 
does not amplify the hypertrophic adaptation to RT.  
 
PN 28: In contrast, some previous studies have used other measures of muscularity, 
such as dual-energy X-ray absorptiometry to assess lean body mass (17) and 
ultrasonography to measure muscle thickness (7), and have found a positive effect of 
PRO following a period of RT. However, these methods are widely considered to 
have lower precision and reliability than MRI (3). Furthermore, other RT studies have 
reported no difference between PRO and PLA regarding changes in either lean body 
mass (34) or muscle thickness (35). By measuring muscle fiber CSA (fCSA), the 
effect of PRO on RT-induced muscle hypertrophy has been determined at the cellular 
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level but with contradictory findings (1, 17, 18, 34). The lack of concurrence may 
reflect the large variability in the histological measurement of fCSA from biopsy 
samples (25) that may not mirror training-induced changes in whole muscle size 
measured with MRI (28). 
 
PN 29: We observed significant increases in biceps brachii and brachialis muscle 
fascicle pennation angle (θp) in both PRO and PLA groups but no difference between 
groups. These findings are in accord with the relative changes in whole muscle 
volume and ACSAmax observed in both training groups but are in contrast to those of 
a previous RT study that reported an increase in gastrocnemius medialis θp in 
participants supplemented with essential amino acids and no change in PLA (35). 
This is surprising, especially as RT is known to increase muscle θp even when no 
nutritional supplementation is provided (13).  
 
PN 30: Together with muscle hypertrophy, neural changes are considered to be the 
major contributors to strength improvements following RT (15) and the current study 
was the first to quantify the neural adaptations to RT in the context of PRO. Voluntary 
muscle activation and antagonist muscle co-activation, assessed with normalized 
sEMG, did not change following 12 weeks elbow flexion RT in either group. This 
finding suggests that elbow flexor muscle activation was very high prior to the 12-wk 
RT period, and that neural adaptations did not confound any potential effect of PRO 
on the strength gains found in this study.  
 
PN 31: Following the 12-wk supplemented RT, elbow flexor 1-RM increased by 
~41% and isometric strength by ~13%, changes that are in accord with previous RT 
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studies on the elbow flexor muscle group (10). However, given that there were no 
differences in neural adaptations or muscle morphology between PRO and PLA 
groups, it was not surprising that RT-induced strength gains did not differ between the 
two groups. This finding is similar to that reported in previous RT studies of the lower 
limb (1, 17, 34) but different to those reporting a significant effect of PRO on RT-
induced increases in 1-RM (8, 9). Although the reasons for these discrepancies are not 
clear, changes in 1-RM are probably influenced by neural adaptations and the 
involvement of stabilizer muscles (29), which were not accounted for in these studies 
and may have confounded their results.  
 
PN 32: Normal dietary behavior, as assessed from two 3-day records of weighed 
nutrient intake, was similar for the PRO and PLA groups both before and during the 
12-wk supplemented RT period, and there was no change over time. Therefore, it 
seems unlikely that this could have confounded our findings. However, we 
acknowledge that a longer recording period and/or additional assessments of weighed 
nutrient intake might have provided a more comprehensive account of habitual diet 
and further reinforced our results. Based on the available evidence, we considered that 
whey protein as opposed to soy or casein (31), supplemented immediately before and 
after each session (14, 33), as well as a dosage of ≥20 g (26), would promote MPS, 
and maximize the hypertrophic response. The conventional PRO supplementation 
approach of this study, i.e. targeted at the time of training, did influence protein intake 
on training days, but did not affect total protein intake averaged over training and 
non-training days. It is possible, therefore, that influencing total protein intake could 
be an important factor in any benefits of PRO, although several previous studies that 
also found no influence of training targeted PRO on total protein intake (17, 20) did 
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find positive effects of PRO on indicators of muscle hypertrophy (17) or strength 
responses (20).  
 
PN 33: While the timing of PRO with respect to a resistance exercise bout has 
previously been shown to influence the augmentation of MPS following a single bout 
of resistance exercise (33), some recent work indicates that the sensitivity of MPS to 
PRO persists for up to 24 h after a bout of resistance exercise (5). Therefore, it is 
feasible that prolonged sensitivity to MPS following each training session in our study 
may have enabled the protein content within the regular meals of the PLA group to 
stimulate similar net protein synthesis to the PRO group. Furthermore, although PRO 
has been found to elevate the anabolic hormone response to multiple-limb resistance 
exercise (21), higher levels of circulating anabolic hormones following multiple-limb 
versus solely upper-limb RT do not appear to affect acute MPS (39) or chronic muscle 
hypertrophy (38). However, while the focus of the current study was on the functional 
and hypertrophic changes with chronic RT, the acute MPS and hormonal responses 
may have helped inform these effects, and future work should consider acute MPS 
and hormonal changes alongside chronic adaptations. Considering the relatively small 
muscle mass trained, and the equivalent training responses of the two groups, the 
habitual protein intake of both groups may have been sufficient to maintain optimal 
net protein synthesis, thus facilitating similar accretion of muscle mass. In this case 
the available free amino acids within the muscle and blood of the PLA group may 
have been adequate to satisfy the protein requirements for increased synthesis 
following each RT bout. It is feasible, therefore, that RT incorporating a much greater 
muscle mass, such as whole body RT, could have a higher protein requirement and 
might benefit from the provision of supplementary protein. However, the few studies 
 22 
that have used MRI to assess muscle hypertrophy following RT of multiple muscle 
groups have demonstrated that PRO has either a marginal (20) or no effect (18).  
 
PN 34: In conclusion, protein supplementation did not augment the adaptations of 
muscle strength and size that occurred after 12 weeks of elbow flexor RT in 
previously untrained young men. We suggest that future studies should use similar 
sensitive measures of muscle size and strength to investigate whether the adaptations 
to RT in different circumstances may be more responsive to protein supplementation, 
such as whole body RT. 
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FIGURE LEGENDS 
FIGURE 1. Overview of the study intervention periods and measurements (A): 1-RM, 
single repetition maximum; MVF, isometric maximum voluntary force (incl. sEMG); 
MRI, magnetic resonance imaging to assess muscle size; US, ultrasound 
measurements of muscle architecture; anthropometry, skinfold measurements, body 
mass and height; Nutrient intake, food and drink intake weighed and recorded over 3-
days; PAL, physical activity level assessed via questionnaire; and the isometric 
strength testing apparatus (B) used to measure elbow flexion and extension MVF. 
 
FIGURE 2. Relative training-induced changes in (A) elbow flexor muscle volume and 
(B) isometric maximum voluntary force (MVF) and single repetition maximum (1-
RM) after 12 weeks of resistance training with placebo (PLA) or protein (PRO) 
supplementation; BB, biceps brachii; BRACH, brachialis; BR, brachioradialis; TOTAL, 
all 3 elbow flexor muscles; relative changes did not differ between PLA and PRO 
groups (P > 0.05); values are mean ± SD.  
 TABLE 1. Characteristics of the PRO and PLA groups before the 12-wk supplemented RT period.  
Variable PLA 
(n = 16) 
PRO 
(n = 17) 
t-test 
P = 
Age (yr) 23.7 ± 2.9 23.1 ± 3.0 0.59 
Body mass (kg) 75.6 ± 11.4 74.9 ± 10.3 0.87 
Height (cm) 177.0 ± 6.5 175.9 ± 6.5 0.65 
% body fat 22.1 ± 6.2 22.5 ± 5.1 0.85 
Habitual physical activity rating 2.62 ± 0.44 2.50 ± 0.34 0.37 
Energy intake (kcal⋅d-1) 2515 ± 706 2482 ± 581 0.89 
Protein intake (g⋅d-1) 101 ± 21 94 ± 24 0.39 
Protein intake (g⋅kg-1⋅d-1) 1.36 ± 0.35 1.26 ± 0.31 0.41 
Isometric MVF (N) 271.2 ± 43.0 253.8 ± 41.1 0.24 
1RM (kg) 13.3 ± 3.2 12.3 ± 2.7 0.37 
Isometric strength response to the initial 3-wk 
RT  period (%) 
+ 5.6  ± 7.5 + 4.9 ± 12.9 0.85 
Elbow flexor muscle volume (cm3) 413.4 ± 73.1 388.3 ± 61.9 0.29 
Elbow flexor muscle ∑ACSAmax (cm2) 28.5 ± 3.9 26.9 ± 4.3 0.29 
Data are means ± SD, and independent t-test P values are displayed. 
  
TABLE 2. Elbow flexor muscle volume, maximum anatomical cross-sectional area (ACSAmax) and 
muscle fascicle pennation (θp) angle before (Pre) and after (Post) the 12-wk RT period, with placebo 
(PLA) or protein (PRO) supplementation before and after every training session. Data are mean ± SD 
and ANOVA group x time (g x t) P-values are displayed. 
 
 
PLA (n = 16) PRO (n = 17) g x t 
Pre Post Pre Post P =  
Muscle Volume (cm3)      
Biceps Brachii  184.6 ± 35.7 214.7 ± 39.4 172.1 ± 29.1 203.0 ± 37.9 0.86 
Brachialis  156.7 ± 28.5 176.4± 31.0 150.1± 28.4 174.3 ± 36.7 0.68 
Brachioradialis  71.6 ± 16.5 82.3 ± 17.5 65.6 ± 12.5 76.9 ± 15.5 0.77 
Total  413.4 ± 73.1 474.1± 80.1 388.3± 61.9 454.8 ± 81.5 0.52 
ACSAmax (cm2)      
Biceps Brachii  12.0 ± 2.3 14.0 ± 2.7 11.1 ± 1.9 13.0 ± 2.3 0.54 
Brachialis  12.3 ± 1.5 14.0 ± 1.6 11.8 ± 2.0 13.6 ± 2.5 0.80 
Brachioradialis  4.2 ± 0.8 4.9 ± 0.8 4.0 ± 0.8 4.7 ± 0.9 0.94 
∑ACSAmax  28.5 ± 3.9 32.9 ± 4.5 26.9 ± 4.3 31.3 ± 5.1 0.87 
θp (º)      
Biceps Brachii 15.1 ± 3.0 17.5 ± 3.8 13.7 ± 2.4 16.2 ± 2.9 0.89 
Brachialis 10.5 ± 1.6 12.0  1.8 11.0 ± 1.7 12.6 ± 1.5 0.65 
  
 TABLE 3. Surface EMG activity at isometric elbow flexion maximum voluntary force (MVF) before 
(Pre) and after (Post) the 12-wk RT period, with placebo (PLA) or protein (PRO) supplementation. 
Data are expressed in absolute values and normalized to: Mmax (agonist muscles: BBL and BBS) or 
maximum sEMG during elbow extension (antagonist muscle: triceps brachii, TB). Data are mean ± SD 
and P-values are shown for ANOVA group x time (g x t) interaction effect and independent t-tests for 
the percentage change (%∆). 
Measure: 
          Muscle 
PLA (n = 16) PRO (n = 17) ANOVA 
g x t P = 
t-test 
%∆ P = Pre Post %∆ Pre Post %∆ 
Absolute Values (mV): 
         Agonists:        BR 
 
0.75 
± 0.38 
 
0.73 
± 0.38 
 
-0.8 
± 26.4 
 
0.67 
± 0.46 
 
0.62 
± 0.33 
 
5.6 
± 37.7 
 
0.80 
 
 
0.58 
                                BBL 0.84 
± 0.54 
0.68 
± 0.48 
-11.3 
± 35.2 
0.59 
± 0.38 
0.48 
± 0.31 
-10.6 
± 33.6 
0.11 
 
0.95 
                                BBS 1.24 
± 0.81 
0.94 
± 0.65 
-15.6 
± 36.9 
1.08 
± 0.71 
0.88 
± 0.47 
-6.2 
± 46.6 
0.70 
 
0.54 
          Antagonist:    TB 0.02 
± 0.03 
0.02 
± 0.01 
12.6 
± 53.1 
0.02 
± 0.03 
0.01 
± 0.01 
-13.3 
± 44.0 
0.09 
 
0.14 
Normalized Values (%): 
          Agonists:       BBL 
 
8.8 
± 5.4 
 
7.5 
± 3.1 
 
-0.9 
± 46.7 
 
9.6 
± 7.2 
 
8.5 
± 4.5 
 
-1.9 
± 38.6 
 
0.91 
 
 
0.95 
                                BBS 10.0 
± 9.2 
10.3 
± 8.1 
13.1 
± 52.3 
12.8 
± 9.6 
10.7 
± 6.3 
2.0 
± 61.3 
0.46 
 
0.60 
          Antagonist:    TB 14.7 
± 10.0 
13.8 
± 9.0 
2.6 
± 39.1 
13.9 
± 6.7 
11.9 
± 6.6 
-3.1 
± 49.9 
0.65 
 
0.72 
  
 TABLE 4. Energy and macronutrient intake during the initial 3-wk RT (no nutritional intervention) and 
12-wk RT (PLA or PRO supplementation) periods. During the 12-wk supplemented RT period, data 
include training and non-training days. Data are mean ± SD and P-values are displayed for independent 
t-tests.  
Nutritional measure:  
3-wk or 12-wk RT period 
PLA (n = 16) 
 
PRO (n = 17) 
 
t-test, 
P = 
Energy intake: 
3-wk RT (kcal·d-1) 
12-wk RT – Normal diet (kcal·d-1) 
12-wk RT – Total intake (kcal·d-1) 
 
2515 ± 706 
2522 ± 672 
2545 ± 672 
 
2482 ± 581 
2480 ± 608 
2572 ± 608 
 
0.89 
0.85 
0.91 
Protein intake:  
3-wk RT (g·d-1) 
3-wk RT (g·kg-1·d-1) 
12-wk RT – Normal diet (g·d-1) 
12-wk RT – Normal diet (g·kg-1·d-1) 
12-wk RT – Total intake (g·d-1) 
12-wk RT – Total intake (g·kg-1·d-1) 
 
101 ± 21 
1.36 ± 0.35 
101 ± 28 
1.35 ± 0.47 
101 ± 28 
1.35 ± 0.47 
 
95 ± 26 
1.28 ± 0.37 
100 ± 23 
1.33 ± 0.32 
117 ± 23 
1.56 ± 0.33 
 
0.39 
0.41 
0.85 
0.88 
0.09 
0.12 
CHO intake:  
3-wk RT (g·d-1) 
3-wk RT (g·kg-1·d-1) 
12-wk RT – Normal diet (g·d-1) 
12-wk RT – Normal diet (g·kg-1·d-1) 
12-wk RT – Total intake (g·d-1) 
12-wk RT – Total intake (g·kg-1·d-1) 
 
325 ± 106 
4.41 ± 1.79 
316.4 ± 89 
4.23 ± 1.34 
322 ± 89 
4.31 ± 1.35 
 
343 ± 101 
4.59 ± 1.38 
341 ± 104 
4.56 ± 1.50 
347 ± 104 
4.64 ± 1.50 
 
0.62 
0.75 
0.47 
0.49 
0.47 
0.50 
Fat intake:  
3-wk RT (g·d-1) 
3-wk RT (g·kg-1·d-1) 
12-wk RT – Normal diet (g·d-1) 
12-wk RT – Normal diet (g·kg-1·d-1) 
 
81 ± 26 
1.10 ± 0.39 
92 ± 37 
1.22 ± 0.56 
 
86 ± 32 
1.16 ± 0.39 
84 ± 34 
1.14 ± 0.53 
 
0.60 
0.57 
0.52 
0.61 
 


